FORMULATIONS CONTAINING NALBUPHINE AND USES THEREOF

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130123294A1
SERIAL NO

13810358

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Immediate release, oral, pharmaceutical formulation including nalbuphine or a pharmaceutically acceptable salt thereof, and at least one hydrophilic granulation carrier, one hydrophilic binder and one lubricant.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DEBREGEAS ET ASSOCIES PHARMA75008 PARIS

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lebon, Christophe Rouvres, FR 11 198
Paul, David Olivier Dreux, FR 2 9
Suplie, Pascal Montaure, FR 33 534

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation